Fumito Ito

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Cancer research communications

Journal for immunotherapy of cancer

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

Roswell Park Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roswell Park Cancer Institute Sep 01 2017

United States

Associate Professor of Oncology :: Surgical Oncology and Center for Immunotherapy

Roswell Park Cancer Institute Oct 01 2015 - Aug 31 2017

United States

Assistant Professor of Oncology :: Surgical Oncology and Center for Immunotherapy

University of Michigan Jul 11 2011 - Aug 31 2015

United States

Assistant Professor of Surgery :: Surgery

Publications

Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, transcriptomic states, and clinical relevance of CX3CR1+ CD8 T cells in melanoma. Cancer research communications (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto, Takaaki Oba, Fumito Ito
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer research communications 4 (7) (2024)
Eihab Abdelfatah, Mark D Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher M Attwood, Junko Matsuzaki, Brahm H Segal, Grace K Dy, Fumito Ito
Predictive and Prognostic Implications of Circulating CX3CR1 + CD8 + T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer research communications 3 (3) (2023)
Joy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, Hongbin Chen, Grace K Dy, Brahm H Segal, Marc S Ernstoff, Fumito Ito
Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy. World journal of oncology 14 (3) (2023)
Takaaki Oba, Kenichi Makino, Ryutaro Kajihara, Toshihiro Yokoi, Ryoko Araki, Masumi Abe, Hans Minderman, Alfred E Chang, Kunle Odunsi, Fumito Ito
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models. Journal for immunotherapy of cancer 9 (5) (2022)
Igor Puzanov, Poornima Subramanian, Yan V Yatsynovich, David M Jacobs, Maya R Chilbert, Umesh C Sharma, Fumito Ito, Steven G Feuerstein, Filip Stefanovic, Benjamin Switzer, Mark D Hicar, Anne B Curtis, Edward J Spangenthal, Grace K Dy, Marc S Ernstoff, Pankit Vachhani, Brian J Page, Nikhil Agrawal, Arjun Khunger, Ankita Kapoor, Alexander Hattoum, Jerome J Schentag
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. Journal for immunotherapy of cancer 9 (6) (2022)
Kenichi Makino, Mark D Long, Ryutaro Kajihara, Satoko Matsueda, Takaaki Oba, Kazunori Kanehira, Song Liu, Fumito Ito
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling. Journal for immunotherapy of cancer 10 (1) (2022)
Xuedan He, Shiqi Zhou, Melissa Dolan, Yuhao Shi, Jianxin Wang, Breandan Quinn, Dushyant Jahagirdar, Wei-Chiao Huang, Moriya Tsuji, Roberto Pili, Fumito Ito, Joaquin Ortega, Scott I Abrams, John M L Ebos, Jonathan F Lovell
Immunization with short peptide particles reveals a functional CD8 + T-cell neoepitope in a murine renal carcinoma model. Journal for immunotherapy of cancer 9 (12) (2022)
Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Ryutaro Kajihara, Kristopher Attwood, Xuefang Cao, Fumito Ito
CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells. Cancer immunology, immunotherapy : CII (2021)
Takaaki Oba, Ryutaro Kajihara, Toshihiro Yokoi, Elizabeth A Repasky, Fumito Ito
Neoadjuvant in situ immunomodulation enhances systemic antitumor immunity against highly metastatic tumors. Cancer research (2021)
Ankit Patel, Takaaki Oba, Ryutaro Kajihara, Toshihiro Yokoi, Scott I Abrams, Fumito Ito
Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression. Journal of immunology (Baltimore, Md. : 1950) 207 (5) (2021)
Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood, Sebastiano Battaglia, Saby George, Gurkamal Chatta, Igor Puzanov, Carl Morrison, Kunle Odunsi, Brahm H Segal, Grace K Dy, Marc S Ernstoff, Fumito Ito
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nature communications 12 (1) (2021)
Fumito Ito, Trupti D Vardam, Michelle M Appenheimer, Kevin H Eng, Sandra O Gollnick, Jason B Muhitch, Sharon S Evans
In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 36 (sup1) (2020)
Takaaki Oba, Mark D Long, Tibor Keler, Henry C Marsh, Hans Minderman, Scott I Abrams, Song Liu, Fumito Ito
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nature communications 11 (1) (2020)
Takaaki Oba, Toshifumi Hoki, Takayoshi Yamauchi, Tibor Keler, Henry C Marsh, Xuefang Cao, Fumito Ito
A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells. Journal of immunology (Baltimore, Md. : 1950) 205 (7) (2020)

Fumito Ito.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fumito Ito